High Risk Breast Cancer Screening Program
- Conditions
- Breast Cancer
- Registration Number
- NCT00509509
- Lead Sponsor
- Organisation for Oncology and Translational Research
- Brief Summary
Objectives:
* To screen population with high risk for breast cancer
* To promote the concept and importance of surveillance mammography
* To find out the incidence of breast cancer in population who are in high risk for breast cancer
* To collect blood samples for molecular analysis
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Female
- > 40 years of age
- Women who have first-degree relative suffered from breast cancer
- Women who have first-degree relative suffered from ovarian cancer
- Family history of male breast cancer
- Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40
- Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members
- Personal history of ovarian cancer
- Personal history of premalignant conditions of breast and ovary
Exclusion Criteria
- Women with mammogram within one year
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular biomarkers are associated with high risk breast cancer in NCT00509509?
How does surveillance mammography improve early detection in high risk breast cancer populations?
What are the comparative outcomes of high risk screening vs standard care in breast cancer prevention?
What adverse events are reported in high risk breast cancer screening programs and how are they managed?
How do blood samples from NCT00509509 contribute to understanding BRCA-related breast cancer mechanisms?
Trial Locations
- Locations (1)
UNIMED Medical Institute
🇭🇰Wanchai, Hong Kong
UNIMED Medical Institute🇭🇰Wanchai, Hong KongLouis WC ChowContact(852)2861 0286lwcchow@unimed.hk